MB07133 for the Treatment of Patients With Unresectable Hepatocellular Carcinoma

Clinical trial NCT06141096 · UNKNOWN

Trial details

NCT number: NCT06141096
Sponsor: Xi'an Xintong Pharmaceutical Research Co.,Ltd.
Status: UNKNOWN
Phase: Phase 2
Study type: INTERVENTIONAL

Safety Issues Effect of Drug Tolerance

Start date: 2020-01-17
Primary completion: 2024-06-30
Enrollment: 91

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.